This is the authors' abstract. We don't add key points for this paper.
The synthesis, stabilization, and structural characterization of high-valent copper complexes are critical for understanding biological and chemical oxidation processes and for developing new catalytic transformations. Herein, we report the ambient generation of a novel terminal mononuclear CuIII–N3 complex supported by a dicarboxamide ligand, H2L (H2L = N,N′-(2,6-diisopropylphenyl)-2,6-pyridinedicarboxamide). The electronic and structural features of the terminal azide ligand play a crucial role in controlling the stability and reactivity of the CuIII-complex. The high-valent complex [(L)CuIII(N3)] (2) was prepared from Bu4N[(L)CuII(N3)] (1) through a one-electron oxidation process. Both complexes 1 and 2 were characterized by X-ray crystallography and UV–vis, 1H/13C NMR, FT-IR, and EPR spectroscopies, and ESI-MS. The single-crystal X-ray structure of 2─a rare example of a crystallographically characterized mononuclear CuIII–N3 complex─revealed shortened Cu–N bond distances (Cu–Navg. = 1.878(2) vs 1.972(1) Å). Fascinatingly, 2 performed direct azidation of very strong C–H bonds in hydrocarbons (e.g.; cyclohexane). We found that complex 2 drives hydrocarbon azidation via hydrogen atom abstraction or basicity-driven PCET and a subsequent radical-capture mechanism. 2 also exhibited aldehyde deformylation, and phenol and phosphine oxidation reactions. Our results found a very interesting new class of metal oxidant with diverse bioinspired reactivity profile.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Panigrahi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: